肺癌
血小板
细胞
肿瘤细胞
癌症研究
群体智能
医学
免疫学
生物
计算机科学
病理
遗传学
机器学习
粒子群优化
作者
Myron G. Best,Nik Sol,Sjors G. J. G. In ‘t Veld,Adrienne Vancura,Mirte Muller,Anna-Larissa N. Niemeijer,Aniko V. Fejes,Lee-Ann Tjon Kon Fat,Anna E. Huis in ‘t Veld,Cyra E Leurs,Tessa Y. Le Large,Laura L. Meijer,Irsan Kooi,François Rustenburg,Pepijn Schellen,Heleen Verschueren,Edward P. Post,Laurine E. Wedekind,Jillian Wilhelmina Paulina Bracht,Michelle Esenkbrink
出处
期刊:Cancer Cell
[Cell Press]
日期:2017-08-01
卷期号:32 (2): 238-252.e9
被引量:320
标识
DOI:10.1016/j.ccell.2017.07.004
摘要
Blood-based liquid biopsies, including tumor-educated blood platelets (TEPs), have emerged as promising biomarker sources for non-invasive detection of cancer. Here we demonstrate that particle-swarm optimization (PSO)-enhanced algorithms enable efficient selection of RNA biomarker panels from platelet RNA-sequencing libraries (n = 779). This resulted in accurate TEP-based detection of early- and late-stage non-small-cell lung cancer (n = 518 late-stage validation cohort, accuracy, 88%; AUC, 0.94; 95% CI, 0.92-0.96; p < 0.001; n = 106 early-stage validation cohort, accuracy, 81%; AUC, 0.89; 95% CI, 0.83-0.95; p < 0.001), independent of age of the individuals, smoking habits, whole-blood storage time, and various inflammatory conditions. PSO enabled selection of gene panels to diagnose cancer from TEPs, suggesting that swarm intelligence may also benefit the optimization of diagnostics readout of other liquid biopsy biosources.
科研通智能强力驱动
Strongly Powered by AbleSci AI